This gene encodes an ETS-domain transcription factor that activates gene expression during myeloid and B-lymphoid cell development. The nuclear protein binds to a purine-rich sequence known as the PU-box found on enhancers of target genes, and regulates their expression in coordination with other transcription factors and cofactors. The protein can also regulate alternative splicing of target genes. Multiple transcript variants encoding different isoforms have been found for this gene.
The ETS domain is the DNA-binding module of PU.1 and other ETS-family transcription factors.
Ray D, Culine S, Tavitain A, Moreau-Gachelin F (May 1990). "The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors". Oncogene. 5 (5): 663–668. PMID 1693183. /wiki/PMID_(identifier)
Oikawa T, Yamada T, Kihara-Negishi F, Yamamoto H, Kondoh N, Hitomi Y, et al. (July 1999). "The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis". Cell Death and Differentiation. 6 (7): 599–608. doi:10.1038/sj.cdd.4400534. PMID 10453070. https://doi.org/10.1038%2Fsj.cdd.4400534
"Entrez Gene: SPI1 spleen focus forming virus (SFFV) proviral integration oncogene spi1". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6688
Chambers C, Cermakova K, Chan YS, Kurtz K, Wohlan K, Lewis AH, et al. (April 2023). "SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia". Cancer Research. 83 (7): 983–996. doi:10.1158/0008-5472.CAN-22-2129. PMC 10071820. PMID 36662812. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071820
Burda P, Laslo P, Stopka T (July 2010). "The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis". Leukemia. 24 (7): 1249–1257. doi:10.1038/leu.2010.104. PMID 20520638. S2CID 1941766. /wiki/Doi_(identifier)
Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A, et al. (February 2019). "PU.1 controls fibroblast polarization and tissue fibrosis". Nature. 566 (7744): 344–349. Bibcode:2019Natur.566..344W. doi:10.1038/s41586-019-0896-x. PMC 6526281. PMID 30700907. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526281
Hallier M, Lerga A, Barnache S, Tavitian A, Moreau-Gachelin F (February 1998). "The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS". The Journal of Biological Chemistry. 273 (9): 4838–4842. doi:10.1074/jbc.273.9.4838. PMID 9478924. https://doi.org/10.1074%2Fjbc.273.9.4838
Zhang P, Behre G, Pan J, Iwama A, Wara-Aswapati N, Radomska HS, et al. (July 1999). "Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1". Proceedings of the National Academy of Sciences of the United States of America. 96 (15): 8705–8710. Bibcode:1999PNAS...96.8705Z. doi:10.1073/pnas.96.15.8705. PMC 17580. PMID 10411939. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17580
Brass AL, Zhu AQ, Singh H (February 1999). "Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers". The EMBO Journal. 18 (4): 977–991. doi:10.1093/emboj/18.4.977. PMC 1171190. PMID 10022840. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171190
Escalante CR, Shen L, Escalante MC, Brass AL, Edwards TA, Singh H, et al. (July 2002). "Crystallization and characterization of PU.1/IRF-4/DNA ternary complex". Journal of Structural Biology. 139 (1): 55–59. doi:10.1016/s1047-8477(02)00514-2. PMID 12372320. /wiki/Doi_(identifier)
Hallier M, Tavitian A, Moreau-Gachelin F (May 1996). "The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb". The Journal of Biological Chemistry. 271 (19): 11177–11181. doi:10.1074/jbc.271.19.11177. PMID 8626664. https://doi.org/10.1074%2Fjbc.271.19.11177